1 |
Rothman N, Stewart WF, Schulte PA. Incorporating biomarkers into cancer epidemiology: A matrix of biomarker and study design categories. Cancer Epidemiol Biomarkers Prev 1995; 4(4): 301-311
|
2 |
Shields PG. Molecular epidemiology. Prog Clin Biol Res 1996; 395: 141-157
ScienceOn
|
3 |
Schenk JM, Kristal AR, Neuhouser ML, Tangen CM, White E, Lin DW, et al. Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: Results from the Prostate Cancer Prevention Trial. Prostate 2009; 69(12): 1303-1311
DOI
ScienceOn
|
4 |
Owen RW. Biomarkers in colorectal cancer. IARC Sci Publ 2001; 154: 101-111
PUBMED
|
5 |
Hulka BS, Wilcosky TC, Griffith JD. Biological Markers in Epidemiology. New York: Oxford University Press; 1990
|
6 |
Kaaks RJ. Biochemical markers as additional measurements in studies of the accuracy of dietary questionnaire measurements: Conceptual issues. Am J Clin Nutr 1997; 65(4 Suppl): 1232S-1239S
DOI
|
7 |
Marshall JR. High-grade prostatic intraepithelial neoplasia as an exposure biomarker for prostate cancer chemoprevention research. IARC Sci Publ 2001; 154: 191-198
PUBMED
|
8 |
Bingham SA, Day NE. Using biochemical markers to assess the validity of prospective dietary assessment methods and the effect of energy adjustment. Am J Clin Nutr 1997; 65(4 Suppl): 1130S-1137S
DOI
|
9 |
Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, Bingham S, et al. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: The OPEN study. Am J Epidemiol 2003; 158(1): 1-13
DOI
ScienceOn
|
10 |
Hulka BS, Margolin BH. Methodological issues in epidemiologic studies using biologic markers. Am J Epidemiol 1992; 135(2): 200-209
DOI
PUBMED
|